Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
The Korean Journal of Gastroenterology
>
2021
>
77
>
5
Volume:
77
Issue:
5
1. MPV17-related Hepatocerebral Mitochondrial DNA Depletion Syndrome
Page:248—252
2. The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer
Page:261—262
3. Symptomatic Esophageal Leiomyoma
Page:258—260
4. Cannulation of the Portal Vein during Endoscopic Retrograde Cholangiopancreatography in a Patient with Choledocholithiasis
Page:253—257
5. How Should We Do Different Approach to Treat Inflammatory Bowel Disease by Gender Difference?
Page:241—247
6. Treatment of Inflammatory Bowel Disease in Elderly Patients – What Are Different and What Should We Know?
Page:231—240
7. How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?
Page:227—230
8. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Page:220—226
9. Suggestions for the Development of Education Guideline for Abdominal US Education Specialists
Page:217—219
10. The Role of Training Institutions and Academic Societies for the Training and Education of GI Fellows
Page:214—216
11. Impact of COVID-19 on Gastroenterology Fellowship Training
Page:205—213
12. MPV17-related Hepatocerebral Mitochondrial DNA Depletion Syndrome
Page:248—252
13. The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer
Page:261—262
14. Symptomatic Esophageal Leiomyoma
Page:258—260
15. Cannulation of the Portal Vein during Endoscopic Retrograde Cholangiopancreatography in a Patient with Choledocholithiasis
Page:253—257
16. How Should We Do Different Approach to Treat Inflammatory Bowel Disease by Gender Difference?
Page:241—247
17. Treatment of Inflammatory Bowel Disease in Elderly Patients – What Are Different and What Should We Know?
Page:231—240
18. How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?
Page:227—230
19. Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Page:220—226
20. Suggestions for the Development of Education Guideline for Abdominal US Education Specialists
Page:217—219
21. The Role of Training Institutions and Academic Societies for the Training and Education of GI Fellows
Page:214—216
22. Impact of COVID-19 on Gastroenterology Fellowship Training
Page:205—213